| Sex differences in Alzheimer’s disease: insights from the multiomics landscape L Guo, MB Zhong, L Zhang, B Zhang, D Cai Biological psychiatry 91 (1), 61-71, 2022 | 112 | 2022 |
| Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis J Cao, MB Zhong, CA Toro, L Zhang, D Cai Neuroscience letters 703, 68-78, 2019 | 77 | 2019 |
| ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury J Cao, FE Gaamouch, JS Meabon, KD Meeker, L Zhu, MB Zhong, ... Scientific reports 7 (1), 11372, 2017 | 71 | 2017 |
| Women in neuroscience: Where are we in 2019? S Machlovi, A Pero, S Ng, M Zhong, D Cai Journal of Neuroscience Research 99 (1), 9, 2020 | 13 | 2020 |
| Exploring a Role for MicroRNA195 (mir195) as a Potential Alzheimer's Disease Biomarker J Hou, J Cao, L Zhu, L Zhang, F El Gaamouch, MB Zhong, G Elder, ... ANNALS OF NEUROLOGY 86, S150-S151, 2019 | | 2019 |
| P1‐084: STRUCTURAL DERIVATIVES OF NIMODIPINE TARGETED AT SYNAPTOJANIN1 AS NOVEL THERAPEUTIC CANDIDATES FOR ALZHEIMER'S DISEASE J Cao, J Hou, L Zhu, L Zhang, F El Gaamouch, MB Zhong, M Ohlmeyer, ... Alzheimer's & Dementia 15, P267-P267, 2019 | | 2019 |
| P2‐250: EXPLORING A ROLE FOR MICRORNA195 (MIR195) AS A POTENTIAL ALZHEIMER'S DISEASE BIOMARKER J Cao, J Hou, L Zhu, L Zhang, F El Gaamouch, MB Zhong, G Elder, ... Alzheimer's & Dementia 15, P679-P679, 2019 | | 2019 |
| [P4–043]: DEVELOPING NOVEL THERAPIES FOR ALZHEIMER'S DISEASE TARGETING BRAIN PHOSPHOLIPID DYSREGULATION D Cai, F El Gaamouch, L Zhu, M Ohlmeyer, M Zhong, MB Zhong, B Zhang Alzheimer's & Dementia 13 (7S_Part_26), P1272-P1273, 2017 | | 2017 |
